Tanshinone IIA can inhibit human pancreatic carcinoma BxPC3 cells through decreasing the protein expressions of IGFR, EGFR, VEGFR and blocking both Ras/Raf/MEK/ERK and Ras/PI3K/AKT/mTOR pathway in vitro and in vivo

被引:0
|
作者
Su, C. C. [1 ]
机构
[1] Changua Christian Hosp, Changhua, Taiwan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-021
引用
收藏
页码:7 / 7
页数:1
相关论文
共 29 条
  • [11] Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways
    Wang, Yu
    Nie, Hao
    Zhao, Xin
    Qin, Yong
    Gong, Xingguo
    BMC CANCER, 2016, 16
  • [12] Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
    McCubrey, James A.
    Steelman, Linda S.
    Chappell, William H.
    Abrams, Stephen L.
    Franklin, Richard A.
    Montalto, Giuseppe
    Cervello, Melchiorre
    Libra, Massimo
    Candido, Saverio
    Malaponte, Grazia
    Mazzarino, Maria C.
    Fagone, Paolo
    Nicoletti, Ferdinando
    Baesecke, Joerg
    Mijatovic, Sanja
    Maksimovic-Ivanic, Danijela
    Milella, Michele
    Tafuri, Agostino
    Chiarini, Francesca
    Evangelisti, Camilla
    Cocco, Lucio
    Martelli, Alberto M.
    ONCOTARGET, 2012, 3 (10) : 1068 - 1111
  • [13] PI-103 and Sorafenib Inhibit Hepatocellular Carcinoma Cell Line Huh7 Proliferation by Blocking Ras/Raf/MAPK and PI3K/AKT/mTOR Pathways
    Gedaly, Roberto
    Angulo, Paul
    Hundley, Jonathan
    Daily, Michael F.
    Chen, Changguo
    Koch, Alvaro
    Evers, B. Mark
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 76 - 77
  • [14] KRAS gene amplification is a distinct molecular subgroup of gastroesophageal adenocarcinoma that may benefit from combined RAS/RAF/MEK/ERK and PI3K/PTEN/AKT/mTOR pathway inhibition
    Henderson, Les
    Xu, Peng
    Rambo, Brittany
    Liao, Wei-Li
    Hembrough, Todd
    Catenacci, Daniel
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [15] Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway
    Wu, Dongdong
    Liu, Zhengguo
    Li, Jianmei
    Zhang, Qianqian
    Zhong, Peiyu
    Teng, Tieshan
    Chen, Mingliang
    Xie, Zhongwen
    Ji, Ailing
    Li, Yanzhang
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [16] Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway
    Dongdong Wu
    Zhengguo Liu
    Jianmei Li
    Qianqian Zhang
    Peiyu Zhong
    Tieshan Teng
    Mingliang Chen
    Zhongwen Xie
    Ailing Ji
    Yanzhang Li
    Cancer Cell International, 19
  • [17] Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway
    Wu, D-D.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 622 - 623
  • [18] A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling pathways
    Dong, Qian
    Yang, Bo
    Han, Ju-Guo
    Zhang, Meng-Meng
    Liu, Wei
    Zhang, Xin
    Yu, Hai-Lan
    Liu, Zheng-Guo
    Zhang, Shi-Hui
    Li, Tao
    Wu, Dong-Dong
    Ji, Xin-Ying
    Duan, Shao-Feng
    CANCER LETTERS, 2019, 455 : 60 - 72
  • [19] Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vitro
    Qian, Xiang
    Bi, Qian-Yu
    Wang, Zeng-Na
    Han, Fang
    Liu, Lu-Ming
    Song, Li-Bin
    Li, Chang-Yu
    Zhang, Ai-Qin
    Ji, Xu-Ming
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 307
  • [20] Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo
    Renshaw, Jane
    Taylor, Kathryn R.
    Bishop, Ryan
    Valenti, Melanie
    Brandon, Alexis De Haven
    Gowan, Sharon
    Eccles, Suzanne A.
    Ruddle, Ruth R.
    Johnson, Louise D.
    Raynaud, Florence I.
    Selfe, Joanna L.
    Thway, Khin
    Pietsch, Torsten
    Pearson, Andrew D.
    Shipley, Janet
    CLINICAL CANCER RESEARCH, 2013, 19 (21) : 5940 - 5951